Will Hologic's Bid for Gen-Probe Spur MDx M&A Activity? | GenomeWeb

NEW YORK (GenomeWeb News) – Following Hologic's $3.7 billion agreement to acquire Gen-Probe, the molecular diagnostics space may be on the verge of some industry consolidation, according to investment analysts.

Yesterday, Hologic announced the $82.75 per-share offer for Gen-Probe, concluding a search Gen-Probe began a year ago for a buyer. The deal has some industry observers considering which other MDx firms may be ripe for a deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.